{"id":6302,"date":"2025-06-06T08:08:00","date_gmt":"2025-06-05T22:38:00","guid":{"rendered":"https:\/\/hepatitissa.asn.au\/communitynews\/?p=6302"},"modified":"2025-08-18T11:14:27","modified_gmt":"2025-08-18T01:44:27","slug":"transforming-hepatitis-b-care-who-takes-the-lead","status":"publish","type":"post","link":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/","title":{"rendered":"Transforming Hepatitis B Care: WHO Takes the Lead"},"content":{"rendered":"\n<p class=\"has-drop-cap\">People living with chronic hepatitis B (CHB) whose treatment had been deferred may be offered therapy as professional bodies review their guidance following the<a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2024\/04\/who-releases-new-hepatitis-b-guidelines\/\"> release of new guidelines<\/a> by the World Health Organization (WHO) in 2024. Momentum is growing to simplify and expand treatment criteria so that more people with chronic hepatitis B will be treated to prevent adverse outcomes.<\/p>\n\n\n\n<p>While issues around side-effects and resistance still exist, effective new drugs have been developed in the last 20 years that are more well-tolerated and have <a href=\"https:\/\/clinicaloptions.com\/activities\/infectious-disease\/functional-cure-for-hepatitis-b\/89165\/viewactivity\" target=\"_blank\" rel=\"noreferrer noopener\">higher barriers to resistance<\/a>. This, together with high prevalence and rising deaths, has prompted a review of guidelines so that more people with CHB, especially those in vulnerable communities with less access to medical services, may be treated in order to save lives and reduce transmission.<\/p>\n\n\n\n<div class=\"wp-block-group has-light-grey-background-color has-background is-layout-constrained wp-container-core-group-is-layout-6acd35de wp-block-group-is-layout-constrained\" style=\"margin-top:0;padding-top:var(--wp--preset--spacing--default);padding-right:var(--wp--preset--spacing--default);padding-bottom:var(--wp--preset--spacing--default);padding-left:var(--wp--preset--spacing--default)\">\n<h3 class=\"wp-block-heading\" style=\"margin-top:0\">BRIEFLY<\/h3>\n\n\n\n<p style=\"margin-bottom:var(--wp--preset--spacing--default-block)\">The new WHO guidelines on hepatitis B, launched on 30 March 2024, have the following priority areas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>expanded treatment eligibility, and inclusion of adolescents;<\/li>\n\n\n\n<li>alternative antiviral therapy regimens;<\/li>\n\n\n\n<li>expanded eligibility for antiviral prophylaxis among pregnant women to prevent mother-to-child transmission;<\/li>\n\n\n\n<li style=\"padding-bottom:0\">HBV diagnostics \u2013 use of point-of-care (POC) DNA assays and <a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2024\/10\/going-reflex-for-timely-results\/\">reflex <\/a>HBV DNA testing;<\/li>\n\n\n\n<li style=\"margin-left:0;padding-bottom:0;padding-left:0\">testing for hepatitis delta (<a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/03\/need-to-act-on-hepatitis-d-now\/\">hepatitis D<\/a>) coinfection.<\/li>\n<\/ul>\n\n\n\n<p style=\"margin-top:0;margin-bottom:0;padding-top:0;padding-bottom:0\">The  guidelines were developed according to procedures established by the WHO Guidelines Review Committee. Clinical recommendations were formulated by a regionally representative and multidisciplinary Guidelines Development Group at a meeting held in May 2023.<\/p>\n\n\n\n<p style=\"margin-bottom:0\">Read the World Hepatitis Alliance <a href=\"https:\/\/www.worldhepatitisalliance.org\/wp-content\/uploads\/2024\/07\/WHA-WHO-Hep-B-Guidelines-Community-Briefing.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">community briefing paper.<\/a><\/p>\n<\/div>\n\n\n\n<p>Globally, hepatitis B accounts for the vast majority of hepatitis deaths and new infections. Over 300 million people live with chronic hepatitis B or C, with hepatitis B accounting for over 254 million. Each year, over 1.3 million die from hepatitis-related liver disease, including cancer. Of these, 1.1 million are due to hepatitis B. Of the 2.2 million new hepatitis infections each year, 1.23 million are hepatitis B.<\/p>\n\n\n\n<p>With only 13 out of a 100 people with CHB diagnosed, 221 million remain unidentified, with no monitoring or care. Of the 33 million who are diagnosed, only 3 out of 100 are receiving treatment. The numbers in Australia are better, but there remain 75,000 undiagnosed out of the estimated 220,000 Australians living with chronic hepatitis B and treatment rates <a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2021\/11\/hepatitis-b-targets-australia-23-years-behind-on-care-24-on-treatment\/\">not meeting targets<\/a>.<\/p>\n\n\n\n<figure data-wp-context=\"{&quot;imageId&quot;:&quot;69e6961382252&quot;}\" data-wp-interactive=\"core\/image\" data-wp-key=\"69e6961382252\" class=\"wp-block-image aligncenter size-large wp-lightbox-container\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"676\" data-wp-class--hide=\"state.isContentHidden\" data-wp-class--show=\"state.isContentVisible\" data-wp-init=\"callbacks.setButtonStyles\" data-wp-on--click=\"actions.showLightbox\" data-wp-on--load=\"callbacks.setButtonStyles\" data-wp-on-window--resize=\"callbacks.setButtonStyles\" src=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-19-152332-1200x676.png\" alt=\"\" class=\"wp-image-6392\" srcset=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-19-152332-1200x676.png 1200w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-19-152332-600x338.png 600w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-19-152332-300x169.png 300w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-19-152332-768x432.png 768w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-19-152332.png 1499w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><button\n\t\t\tclass=\"lightbox-trigger\"\n\t\t\ttype=\"button\"\n\t\t\taria-haspopup=\"dialog\"\n\t\t\taria-label=\"Enlarge\"\n\t\t\tdata-wp-init=\"callbacks.initTriggerButton\"\n\t\t\tdata-wp-on--click=\"actions.showLightbox\"\n\t\t\tdata-wp-style--right=\"state.imageButtonRight\"\n\t\t\tdata-wp-style--top=\"state.imageButtonTop\"\n\t\t>\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"12\" height=\"12\" fill=\"none\" viewBox=\"0 0 12 12\">\n\t\t\t\t<path fill=\"#fff\" d=\"M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z\" \/>\n\t\t\t<\/svg>\n\t\t<\/button><\/figure>\n\n\n\n<p>To add to the complexity, of the 254 million around the world living with hepatitis B, 12 million are also infected with <a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/03\/need-to-act-on-hepatitis-d-now\/\">hepatitis D, a virus that exists only in the presence of the hepatitis B virus<\/a> and accelerates progression of liver disease with devastating outcomes. A <a href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/05\/the-hepatitis-d-global-landscape\">recent survey<\/a> by the World Hepatitis Alliance has found very low levels of awareness about hepatitis D and limited access to testing and treatment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Hepatitis Delta<\/h2>\n\n\n\n<p>One stand-out recommendation in the 2024 WHO guidelines is <strong>reflex testing for hepatitis D<\/strong> in everyone living with chronic hepatitis B. This is the first time WHO guidelines have discussed hepatitis D. Changes to testing guidelines include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The use of non-invasive tests to determine eligibility for treatment and point-of-care tests for hepatitis B status are recommended in situations where access to other traditional assessment tools are limited.<\/li>\n\n\n\n<li>Testing for <strong>all<\/strong> pregnant women<\/li>\n\n\n\n<li>Reflex testing for hepatitis D<\/li>\n<\/ul>\n\n\n\n<figure data-wp-context=\"{&quot;imageId&quot;:&quot;69e6961382870&quot;}\" data-wp-interactive=\"core\/image\" data-wp-key=\"69e6961382870\" class=\"wp-block-image aligncenter size-large wp-lightbox-container\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"658\" data-wp-class--hide=\"state.isContentHidden\" data-wp-class--show=\"state.isContentVisible\" data-wp-init=\"callbacks.setButtonStyles\" data-wp-on--click=\"actions.showLightbox\" data-wp-on--load=\"callbacks.setButtonStyles\" data-wp-on-window--resize=\"callbacks.setButtonStyles\" src=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515-1200x658.png\" alt=\"\" class=\"wp-image-6394\" srcset=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515-1200x658.png 1200w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515-600x329.png 600w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515-300x164.png 300w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515-768x421.png 768w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515-1536x842.png 1536w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132515.png 1709w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><button\n\t\t\tclass=\"lightbox-trigger\"\n\t\t\ttype=\"button\"\n\t\t\taria-haspopup=\"dialog\"\n\t\t\taria-label=\"Enlarge\"\n\t\t\tdata-wp-init=\"callbacks.initTriggerButton\"\n\t\t\tdata-wp-on--click=\"actions.showLightbox\"\n\t\t\tdata-wp-style--right=\"state.imageButtonRight\"\n\t\t\tdata-wp-style--top=\"state.imageButtonTop\"\n\t\t>\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"12\" height=\"12\" fill=\"none\" viewBox=\"0 0 12 12\">\n\t\t\t\t<path fill=\"#fff\" d=\"M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z\" \/>\n\t\t\t<\/svg>\n\t\t<\/button><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Fibrosis and Co-infections<\/h2>\n\n\n\n<p>Other updated recommendations include treatment for <strong>all adults and adolescents<\/strong> with chronic hepatitis B, including pregnant women and girls and women of reproductive age, who meet one of the following criteria:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>stage 2 fibrosis<\/strong> or above<\/li>\n\n\n\n<li>high viral load (over 2000 IU\/mL) and above normal ALT<\/li>\n\n\n\n<li>regardless of test scores, <strong>presence of co-infections<\/strong> (HIV, hepatitis D or hepatitis C), family history of liver cancer or cirrhosis, immune suppression, other conditions such as metabolic dysfunction-associated fatty liver disease (MAFLD), or symptoms outside of the liver,<\/li>\n\n\n\n<li>where HBV DNA testing is not available, persistently abnormal ALT levels<\/li>\n\n\n\n<li>treatment for any HBV-positive pregnant women in settings where hepatitis B DNA and e Antigen testing is not available.<\/li>\n<\/ul>\n\n\n\n<p>The significant change \u2013 while maintaining current criteria for treatment \u2013 is the recommendation to <strong>expand treatment eligibility to include people with stage 2 fibrosis <\/strong>for whom treatment is deferred under previous guidelines.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"782\" height=\"689\" src=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132846.png\" alt=\"\" class=\"wp-image-6404\" srcset=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132846.png 782w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132846-600x529.png 600w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132846-300x264.png 300w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132846-768x677.png 768w\" sizes=\"auto, (max-width: 782px) 100vw, 782px\" \/><figcaption class=\"wp-element-caption\">A simple assessment from Hepatitis B Foundation for people to decide if they should speak to their doctor.<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Simplified Testing<\/h2>\n\n\n\n<p>The new WHO guidelines provides for the diagnosis of fibrosis using non-invasive point of care APRI tests or a fibrosis scan, thus simplifying the process. With the expansion of treatment criteria to stage 2 fibrosis, the APRI test becomes a more reliable tool as it is significantly <a href=\"https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/hbv-2024-webinar-slides.pdf#page=35\" target=\"_blank\" rel=\"noreferrer noopener\">more accurate in picking up positives in the earlier stages<\/a> of liver scarring (fibrosis) than in more advanced stages (cirrhosis).<\/p>\n\n\n\n<p>By allowing alternatives to more costly or complex testing as assessment tools, access to treatment is simplified, a feature especially useful for low- and middle-income countries with limited access to HBV DNA testing. This allows for easier entry to treatment to prevent the onset of cirrhosis and liver cancer.<\/p>\n\n\n\n<p>People with <strong>co-infections<\/strong> such as HIV, hepatitis D, diabetes or MAFLD, or a family history of liver cancer, are <strong>all recommended for treatment<\/strong> as they have a higher risk the liver disease progressing. In addition, recommendation for treatment is for the first time, open to adolescents i.e. any person over the age of 12.<\/p>\n\n\n\n<figure data-wp-context=\"{&quot;imageId&quot;:&quot;69e6961382f62&quot;}\" data-wp-interactive=\"core\/image\" data-wp-key=\"69e6961382f62\" class=\"wp-block-image aligncenter size-large wp-lightbox-container\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"671\" data-wp-class--hide=\"state.isContentHidden\" data-wp-class--show=\"state.isContentVisible\" data-wp-init=\"callbacks.setButtonStyles\" data-wp-on--click=\"actions.showLightbox\" data-wp-on--load=\"callbacks.setButtonStyles\" data-wp-on-window--resize=\"callbacks.setButtonStyles\" src=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639-1200x671.png\" alt=\"\" class=\"wp-image-6395\" srcset=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639-1200x671.png 1200w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639-600x336.png 600w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639-300x168.png 300w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639-768x430.png 768w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639-1536x859.png 1536w, https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/Screenshot-2025-05-23-132639.png 1684w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><button\n\t\t\tclass=\"lightbox-trigger\"\n\t\t\ttype=\"button\"\n\t\t\taria-haspopup=\"dialog\"\n\t\t\taria-label=\"Enlarge\"\n\t\t\tdata-wp-init=\"callbacks.initTriggerButton\"\n\t\t\tdata-wp-on--click=\"actions.showLightbox\"\n\t\t\tdata-wp-style--right=\"state.imageButtonRight\"\n\t\t\tdata-wp-style--top=\"state.imageButtonTop\"\n\t\t>\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"12\" height=\"12\" fill=\"none\" viewBox=\"0 0 12 12\">\n\t\t\t\t<path fill=\"#fff\" d=\"M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z\" \/>\n\t\t\t<\/svg>\n\t\t<\/button><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Pregnancy<\/h2>\n\n\n\n<p>The new approach to hepatitis B management in pregnant women recommends hepatitis B antigen or DNA testing for<strong> all<\/strong> pregnant women and antiviral therapy for women who meet the traditional criteria \u2013 HBV DNA \u2265200,000 IU\/mL or a positive hepatitis B e-Antigen (HBeAg). In addition to that however, a new recommendation gives <strong>all <\/strong>HBsAg-positive pregnant women in settings with no access to the above tests, the <a href=\"https:\/\/clinicaloptions.com\/activities\/infectious-disease\/chronic-hbv\/39544\/viewactivity\" target=\"_blank\" rel=\"noreferrer noopener\">option to take anti-viral drugs<\/a> to prevent mother to child transmission, should they choose to.<\/p>\n\n\n\n<p>This addresses the issue of barriers to accessing hepatitis B DNA testing and hepatitis B eAntigen testing that may prevent otherwise eligible women from getting preventive treatment. Treatment is recommended from the second trimester of pregnancy until at least delivery or completion of the infant HBV vaccination.<\/p>\n\n\n\n<figure class=\"wp-block-pullquote\"><blockquote><p>The <a href=\"https:\/\/www.hepb.org\/about-us\/mission-and-history\/\" target=\"_blank\" rel=\"noreferrer noopener\">Hepatitis B Foundation<\/a>, issued a <a href=\"https:\/\/www.hepb.org\/news-and-events\/treating-hepatitis-b-position-statement\/\" target=\"_blank\" rel=\"noreferrer noopener\">position statement<\/a> calling for treatment to be made available to people living with chronic hepatitis B<\/p><\/blockquote><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Treatments<\/h2>\n\n\n\n<p>In terms of treatment regimens, the guidelines maintain the recommendation of using entecavir and tenofovir disoproxil fumarate (TDF) as preferred regimens with the alternative of using TDF in combination with other drugs where its availability is limited. New recommendations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>reserving the more costly new drug, tenofovir alafenamide fumarate (TAF), for people with bone or kidney disease, <\/li>\n\n\n\n<li>using only TDF and TAF for MTCT preventive treatment as entecavir has been associated with foetal defects, and <\/li>\n\n\n\n<li>using entecavir for children between three and twelve and TAF for those aged 12 or over.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Community Response<\/h2>\n\n\n\n<p>Following the release of the new WHO guidelines, the <a href=\"https:\/\/www.hepb.org\/about-us\/mission-and-history\/\" target=\"_blank\" rel=\"noreferrer noopener\">Hepatitis B Foundation<\/a>, issued a <a href=\"https:\/\/www.hepb.org\/news-and-events\/treating-hepatitis-b-position-statement\/\" target=\"_blank\" rel=\"noreferrer noopener\">position statement<\/a> calling for treatment to be made available to people living with chronic hepatitis B. The statement was crafted by 28 prominent researchers and health professionals with an additional 120 signatories. <\/p>\n\n\n\n<p>The <a href=\"https:\/\/www.worldhepatitisalliance.org\/about\/\" target=\"_blank\" rel=\"noreferrer noopener\">World Hepatitis Alliance<\/a> and the Hepatitis B Foundation have both produced community-friendly, easy to read information documents explaining the key changes. The WHA community briefing paper also includes page references to the official WHO document to assist in reading and understanding the full guidelines. Click on the images or links below to read the documents.<\/p>\n\n\n\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-media-text is-stacked-on-mobile is-image-fill-element\" style=\"grid-template-columns:27% auto\"><figure class=\"wp-block-media-text__media\"><a href=\"https:\/\/www.worldhepatitisalliance.org\/wp-content\/uploads\/2024\/07\/WHA-WHO-Hep-B-Guidelines-Community-Briefing.pdf\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"175\" height=\"248\" src=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/WHA-community-briefing-web.png\" alt=\"\" class=\"wp-image-6398 size-full\" style=\"object-position:50% 50%\"\/><\/a><\/figure><div class=\"wp-block-media-text__content\">\n<p>The World Hepatitis Alliance community briefing paper gives a summary of the new WHO guidelines on the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. References to the WHO document are provided with the summary of each section. Click <a href=\"https:\/\/www.worldhepatitisalliance.org\/wp-content\/uploads\/2024\/07\/WHA-WHO-Hep-B-Guidelines-Community-Briefing.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a> or on the image to read.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-media-text is-image-fill-element\" style=\"grid-template-columns:27% auto\"><figure class=\"wp-block-media-text__media\"><a href=\"https:\/\/www.hepb.org\/assets\/WHO-Treatment-Guidelines-Final-Simplified-.pdf\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"175\" height=\"248\" src=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/hbfoundation-factsheet-web.png\" alt=\"\" class=\"wp-image-6399 size-full\" style=\"object-position:50% 50%\"\/><\/a><\/figure><div class=\"wp-block-media-text__content\">\n<p>The Hepatitis Foundation fact-sheet on the WHO guidelines include a simple checklist for people living with chronic hepatitis B to assess if they should talk to their GPs about treatment. Click on the image or <a href=\"https:\/\/www.hepb.org\/assets\/WHO-Treatment-Guidelines-Final-Simplified-.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a> to read.<br><em><strong>Note: <\/strong>There are as yet no updates from Australian institutions, so practitioners may or may not be open to be approached for discussion<\/em>.<\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Sources<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bridging the Gap to a Functional Cure for Hepatitis B, Dr Su Wang, 21 April 2025 &#8211; <a href=\"https:\/\/clinicaloptions.com\/activities\/infectious-disease\/functional-cure-for-hepatitis-b\/89165\/viewactivity\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/clinicaloptions.com\/activities\/infectious-disease\/functional-cure-for-hepatitis-b\/89165\/viewactivity<\/a><\/li>\n\n\n\n<li>World Health Organisation Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection &#8211; <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240090903\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.who.int\/publications\/i\/item\/9789240090903<\/a><\/li>\n\n\n\n<li>WHO hepatitis B guidelines on the prevention, diagnosis care and treatment for people with chronic hepatitis B infection \u2013 Technical Briefing Webinar &#8211; <a href=\"https:\/\/www.youtube.com\/watch?v=cRPhH0E_Euc\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.youtube.com\/watch?v=cRPhH0E_Euc<\/a><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Credits<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Slides courtesy of the WHO Global Webinar: Technical Briefing on 2024 WHO Hepatitis B Guidelines on Diagnosis Treatment and Service. https:\/\/www.youtube.com\/watch?v=cRPhH0E_Euc <\/li>\n\n\n\n<li>Header image composite of artwork from the following: Family by Tetiana Garkusher via iStock; Liver by anna42f via iStock; Virus &#8211; \u0415\u043b\u0435\u043d\u0430 \u0412\u0435\u0440\u0445\u043e\u0442\u0443\u0440\u043e\u0432\u0430 via iStock<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Momentum is growing to simplify and expand treatment criteria so that more people with chronic hepatitis B will be treated.<\/p>\n","protected":false},"author":2,"featured_media":6391,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","footnotes":""},"categories":[13,11],"tags":[39,228,243,315,34],"issue":[],"ppma_author":[56],"class_list":["post-6302","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-living-with-hepatitis","category-policies-research","tag-treatment","tag-testing","tag-pregnancy","tag-who","tag-hepatitis-b"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Transforming Hepatitis B Care: WHO Takes the Lead | HepSA Community News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transforming Hepatitis B Care: WHO Takes the Lead | HepSA Community News\" \/>\n<meta property=\"og:description\" content=\"Momentum is growing to simplify and expand treatment criteria so that more people with chronic hepatitis B will be treated.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\" \/>\n<meta property=\"og:site_name\" content=\"HepSA Community News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HepatitisSA\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T22:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-18T01:44:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1152\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Cecilia Lim\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hep_sa\" \/>\n<meta name=\"twitter:site\" content=\"@hep_sa\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cecilia Lim\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\"},\"author\":{\"name\":\"Cecilia Lim\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/person\/efdf385408c3eb224631b1314de31e49\"},\"headline\":\"Transforming Hepatitis B Care: WHO Takes the Lead\",\"datePublished\":\"2025-06-05T22:38:00+00:00\",\"dateModified\":\"2025-08-18T01:44:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\"},\"wordCount\":1425,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#organization\"},\"image\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg\",\"keywords\":[\"treatment\",\"testing\",\"pregnancy\",\"WHO\",\"Hepatitis B\"],\"articleSection\":[\"Living with Hepatitis\",\"Policies &amp; Research\"],\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\",\"url\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\",\"name\":\"Transforming Hepatitis B Care: WHO Takes the Lead | HepSA Community News\",\"isPartOf\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg\",\"datePublished\":\"2025-06-05T22:38:00+00:00\",\"dateModified\":\"2025-08-18T01:44:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage\",\"url\":\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg\",\"contentUrl\":\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg\",\"width\":2048,\"height\":1152},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hepatitissa.asn.au\/communitynews\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transforming Hepatitis B Care: WHO Takes the Lead\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#website\",\"url\":\"https:\/\/hepatitissa.asn.au\/communitynews\/\",\"name\":\"HepSA Community News\",\"description\":\"Hepatitis news and views from South Australia\",\"publisher\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hepatitissa.asn.au\/communitynews\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#organization\",\"name\":\"Hepatitis SA\",\"url\":\"https:\/\/hepatitissa.asn.au\/communitynews\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2024\/03\/HepSA_rgb.png\",\"contentUrl\":\"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2024\/03\/HepSA_rgb.png\",\"width\":2025,\"height\":955,\"caption\":\"Hepatitis SA\"},\"image\":{\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/HepatitisSA\",\"https:\/\/x.com\/hep_sa\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/person\/efdf385408c3eb224631b1314de31e49\",\"name\":\"Cecilia Lim\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=gafa69379198950dc40495a8dfb125bd3\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=g\",\"caption\":\"Cecilia Lim\"},\"url\":\"https:\/\/hepatitissa.asn.au\/communitynews\/author\/cecilia-lim\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transforming Hepatitis B Care: WHO Takes the Lead | HepSA Community News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/","og_locale":"en_US","og_type":"article","og_title":"Transforming Hepatitis B Care: WHO Takes the Lead | HepSA Community News","og_description":"Momentum is growing to simplify and expand treatment criteria so that more people with chronic hepatitis B will be treated.","og_url":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/","og_site_name":"HepSA Community News","article_publisher":"https:\/\/www.facebook.com\/HepatitisSA","article_published_time":"2025-06-05T22:38:00+00:00","article_modified_time":"2025-08-18T01:44:27+00:00","og_image":[{"width":2048,"height":1152,"url":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg","type":"image\/jpeg"}],"author":"Cecilia Lim","twitter_card":"summary_large_image","twitter_creator":"@hep_sa","twitter_site":"@hep_sa","twitter_misc":{"Written by":"Cecilia Lim","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#article","isPartOf":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/"},"author":{"name":"Cecilia Lim","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/person\/efdf385408c3eb224631b1314de31e49"},"headline":"Transforming Hepatitis B Care: WHO Takes the Lead","datePublished":"2025-06-05T22:38:00+00:00","dateModified":"2025-08-18T01:44:27+00:00","mainEntityOfPage":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/"},"wordCount":1425,"commentCount":0,"publisher":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#organization"},"image":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage"},"thumbnailUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg","keywords":["treatment","testing","pregnancy","WHO","Hepatitis B"],"articleSection":["Living with Hepatitis","Policies &amp; Research"],"inLanguage":"en-AU","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/","url":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/","name":"Transforming Hepatitis B Care: WHO Takes the Lead | HepSA Community News","isPartOf":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage"},"image":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage"},"thumbnailUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg","datePublished":"2025-06-05T22:38:00+00:00","dateModified":"2025-08-18T01:44:27+00:00","breadcrumb":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/"]}]},{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#primaryimage","url":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg","contentUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2025\/06\/header-img-scaled.jpg","width":2048,"height":1152},{"@type":"BreadcrumbList","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/2025\/06\/transforming-hepatitis-b-care-who-takes-the-lead\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hepatitissa.asn.au\/communitynews\/"},{"@type":"ListItem","position":2,"name":"Transforming Hepatitis B Care: WHO Takes the Lead"}]},{"@type":"WebSite","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#website","url":"https:\/\/hepatitissa.asn.au\/communitynews\/","name":"HepSA Community News","description":"Hepatitis news and views from South Australia","publisher":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hepatitissa.asn.au\/communitynews\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-AU"},{"@type":"Organization","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#organization","name":"Hepatitis SA","url":"https:\/\/hepatitissa.asn.au\/communitynews\/","logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/logo\/image\/","url":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2024\/03\/HepSA_rgb.png","contentUrl":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-content\/uploads\/2024\/03\/HepSA_rgb.png","width":2025,"height":955,"caption":"Hepatitis SA"},"image":{"@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HepatitisSA","https:\/\/x.com\/hep_sa"]},{"@type":"Person","@id":"https:\/\/hepatitissa.asn.au\/communitynews\/#\/schema\/person\/efdf385408c3eb224631b1314de31e49","name":"Cecilia Lim","image":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=gafa69379198950dc40495a8dfb125bd3","url":"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=g","caption":"Cecilia Lim"},"url":"https:\/\/hepatitissa.asn.au\/communitynews\/author\/cecilia-lim\/"}]}},"authors":[{"term_id":56,"user_id":2,"is_guest":0,"slug":"cecilia-lim","display_name":"Cecilia Lim","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/0791a46acf6147a34520719a3f0680a122d9e93c36d981f734e9d7d3d5a24b50?s=96&d=mm&r=g","1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts\/6302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/comments?post=6302"}],"version-history":[{"count":22,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts\/6302\/revisions"}],"predecessor-version":[{"id":6630,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/posts\/6302\/revisions\/6630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/media\/6391"}],"wp:attachment":[{"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/media?parent=6302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/categories?post=6302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/tags?post=6302"},{"taxonomy":"issue","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/issue?post=6302"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/hepatitissa.asn.au\/communitynews\/wp-json\/wp\/v2\/ppma_author?post=6302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}